Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Chlamydia pneumoniae infection, chronic inflammation and risk of lung cancer Anil Chaturvedi NCI, DCEG, IIB PLCO Apr 21, 2006 2005-0014
Serum Levels of Cytokines, Other Immunologic Markers and non-Hodgkin Lymphoma: A Nested Case-Control Study in the PLCO Trial Mark Purdue NCI, DCEG, OEEB PLCO Apr 21, 2006 2005-0015
Genetic variation in the vitamin E blood transport, cellular uptake, and metabolism pathway and prostate cancer risk Demetrius Albanes Extramural PLCO Apr 21, 2006 2005-0018
Serum 25-hydroxyvitamin D, dietary vitamin D and non-Hodgkin Lymphoma: a Nested Case Control Study in the PLCO Trial Mark Purdue NCI, DCEG, OEEB PLCO Apr 21, 2006 2005-0021
Insulin Resistance-Related Metabolic Markers and Pancreatic Cancer Risk Rachael Stolzenberg-Solomon NCI, DCEG, NEB PLCO Apr 21, 2006 2005-0024
Biomarkers and genetic polymorphisms of one-carbon metabolism and risk of lymphoid cancers Unhee Lim NCI, DCEG, NEB PLCO Apr 21, 2006 2005-0025
Alcohol intake, genes responsible for alcohol metabolism, and risk of breast cancer in the PLCO cohort Catherine McCarty Marshfield Clinic Research Foundation PLCO Apr 21, 2006 2005-0027
Measuring carcinogen metabolite levels in long-term smokers and estimating the risk of lung cancer Timothy Church University of Minnesota PLCO Apr 21, 2006 2005-0029
Evaluating Screening Bias in Risk Factor Studies of Lung Cancer Nested in the PLCO Trial Timothy Church University of Minnesota PLCO Mar 31, 2006 2006-0307
Cell Cycle Variants and Metastatic Prostate Cancer Risk Adam Kibel Washington University PLCO Aug 17, 2005 2005-0001
Chromosomal aberrations in cultured peripheral blood lymphocytes and subsequent risk of leukemia and lymphoma Nathaniel Rothman - PLCO Aug 17, 2005 2005-0002
C-GEMS: Cancer Genetic Markers of Susceptibility A Strategic Initiative to Identify Novel Genetic Determinants of Cancer Mitchell Machiela NCI, DCEG, LGS PLCO Aug 17, 2005 2005-0003
Telomere length, mitochondrial DNA mass, and risk for major chronic diseases Richard Hayes New York University PLCO Aug 17, 2005 2005-0006
Breast Cancer: Molecular Epidemiology in the PLCO EEMS Cohort - Hormones and Growth Factors Regina Ziegler NCI, DCEG, EBP PLCO Aug 17, 2005 2005-0007
Multiplexed Assay of Serum Biomarkers for Pancreatic Cancer Anna Lokshin University of Pittsburgh PLCO Aug 17, 2005 2005-0008
Phase III validation using PLCO specimens of a consensus panel of ovarian cancer biomarkers developed by SPORE/EDRN investigators Daniel W. Cramer Brigham and Women's Hospital / Harvard Medical School PLCO Aug 17, 2005 2005-0009
Breast Cancer: Molecular Epidemiology in the PLCO EEMS Cohort- Nutritional Factors Regina Ziegler NCI, DCEG, EBP PLCO Aug 17, 2005 2005-0010
Inflammation regulation: Gene variants and inflammatory markers in colorectal neoplasia Sonja Berndt NCI, DCEG, OEEB PLCO Aug 17, 2005 2005-0011
Iron homeostasis and colorectal adenoma risk in the Prostate, Lung, Colorectal & Ovarian (PLCO) Cancer Screening Trial Amanda Cross NCI, DCEG, NEB PLCO Aug 17, 2005 2005-0012
Functional DNA Repair Assays for Lung Cancer Risk: Prospective Analysis Alice Sigurdson NCI PLCO 2005-0013